Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 45 EP applications Frances Salisbury has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP10855775

METHOD FOR REDUCING DNA IMPURITIES IN VIRAL COMPOSITIONS

IPC classification:
C12R 1/93, C12N 7/02, A61P 31/14, A61K 39/205, A61K 39/12
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
The patent has been granted
EP12796540

DRUG DELIVERY DEVICE EMPLOYING WICKING RELEASE WINDOW

IPC classification:
A61F 11/00
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12830226

POLYPEPTIDE VACCINE

IPC classification:
A61K 38/00, A61P 35/00
Applicant:
Agency for Science, Technology and Research
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12856743

METHODS FOR IMPROVING MEDICAL THERAPIES

IPC classification:
A61K 48/00, A61K 39/395, A61P 35/00
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13711111

PROBIOTIC BACTERIA

IPC classification:
A61K 35/74, A61K 8/99, A61P 31/04, A61P 17/00
Applicant:
University of Manchester
Agent:
Appleyard Lees Ltd
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13784884

ENHANCED AFFINITY T CELL RECEPTORS AND METHODS FOR MAKING THE SAME

IPC classification:
A61K 35/12, C12N 15/867, C12N 5/10, C12N 5/0783, C07K 19/00, A61P 35/00
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13787706

METHODS FOR PREDICTING AND DETECTING CANCER RISK

IPC classification:
G01N 33/574, C12Q 1/68, C12N 15/11
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13762617

CYCLODEXTRIN FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES

IPC classification:
A61K 45/06, A61K 31/724, A61K 31/355, A61P 25/00, A61P 3/00
Agent:
Frances Salisbury, Mewburn Ellis LLP
Agent:
Holger Adam, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13860303

SYSTEM AND METHOD FOR DERIVING PARAMETERS FOR HOMEOSTATIC FEEDBACK CONTROL OF AN INDIVIDUAL

IPC classification:
A61B 5/00, G06F 19/10, G06F 17/10, G01N 33/78
Applicant:
Agency for Science, Technology and Research
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13862131

SPECIFIC INTERNALIZATION OF NANOPARTICLES INTO PROTEIN CAGES

IPC classification:
C12N 9/10, B82Y 40/00
Applicant:
Nanyang Technological University
Applicant:
Agency for Science, Technology and Research
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13869801

SELF-ASSEMBLED ULTRASHORT PEPTIDES HYDROGELS FOR WOUND HEALING, SKIN CARE AND COSMETICS APPLICATIONS

IPC classification:
A61K 47/42, A61K 38/08, A61K 38/07, A61K 38/06, C07K 7/06, C07K 5/103, C07K 5/083
Applicant:
Agency for Science, Technology and Research
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14701975

METHODS AND MEANS FOR INCREASING STRESS TOLERANCE AND BIOMASS IN PLANTS

IPC classification:
C12N 15/82, C12N 15/55, C12N 9/80
Applicant:
Bayer CropScience LP
Agent:
Frances Salisbury, Mewburn Ellis LLP
Agent:
Jan G.M. Desomer, Bayer CropScience NV
Status:
GRANT OF PATENT INTENDED
EP14763190

DUAL REACTIVITY POTENT KUNITZ INHIBITOR OF FIBRINOLYSIS

IPC classification:
C12N 15/63, C07K 19/00, C07K 14/81
Applicant:
University of California
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14778282

IMMUNOLOGICALLY ACTIVE POLYPEPTIDE

IPC classification:
C12N 15/13, C07K 16/28
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14728193

T CELL EPITOPES DERIVED FROM ALT A 1 OR ALT A 5 FOR THE TREATMENT OF ALTERNARIA ALTERNATA ALLERGY

IPC classification:
A61P 37/08, C07K 14/37, A61K 39/35
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15752505

AN OCULAR DRAINAGE DEVICE AND METHOD OF MANUFACTURING THEREOF

IPC classification:
A61F 9/007
Applicant:
National University Hospital (Singapore) Pte Ltd
Applicant:
National University of Singapore
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14792963

DOUBLE BARREL SYRINGE AND METHOD TO USE SAME FOR PLACEMENT CONFIRMATION AND JOINT SPACE INJECTION

IPC classification:
A61B 5/00, A61M 5/31, A61M 5/19, A61B 8/08
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15707853

VASCULAR GRAFTS AND METHOD FOR PRESERVING PATENCY OF SAME

IPC classification:
A61L 31/14, A61L 31/04
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14812105

WITHANOLIDES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

IPC classification:
A61P 25/28, A61K 31/58, C07J 71/00
Applicant:
Université Laval
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15733324

PORTABLE SECURING DEVICE

IPC classification:
A45B 9/00, A61H 3/02, A45B 3/00, A45B 1/04
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15748962

ROTATABLE RACK SYSTEM

IPC classification:
A01G 1/00, A01G 9/24, A01G 9/02, A01G 31/06, A01G 31/04
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16169037

DIETS FOR REDUCING LEVELS OF DISEASE ASSOCIATED PROTEINS

IPC classification:
A61K 31/401, A61K 31/522, A63D 15/00
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP15721094

METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY

IPC classification:
C12N 5/0783, C12N 5/0781
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15708687

NANO OR MACRO MATERIAL FUNCTIONALIZATION AND SELF ASSEMBLED CONSTRUCTION MEDIATED BY TRIS(TRIMETHYLSILYL)SILANE

IPC classification:
C08K 9/00, C01B 32/05, C09C 1/56
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15783769

SYNTHETIC HAPTEN CARRIER COMPOSITIONS AND METHODS

IPC classification:
A61K 39/385, A61K 38/16, A61K 38/00
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15812260

ANALYSIS CARTRIDGE AND METHOD FOR USING SAME

IPC classification:
G01N 33/497, G01N 1/02, G01N 1/22, A61B 5/097, A61B 5/08, A61B 10/00
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15811411

FLUORESCENCE DETECTION ASSEMBLY

IPC classification:
C12M 1/34
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15812820

METHOD AND DEVICE FOR CARBONYL DETECTION AND QUANTITATION

IPC classification:
G01N 21/64
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15836640

METHODS FOR THE PRODUCTION AND USE OF MYCELIAL LIQUID TISSUE CULTURE

IPC classification:
A23L 27/00
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15831971

DIAGNOSIS OF CANCER

IPC classification:
A61K 39/395, G01N 33/574
Applicant:
Agency for Science, Technology and Research
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP15771803

METHODS TO DIAGNOSE AND TREAT MULTIPLE SCLEROSIS VIA DETECTION OF ALTERED PROTEIN COMPONENTS OF SERUM

IPC classification:
G01N 33/68, A61K 38/00, G01N 33/564
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP14802991

CARDIOVASCULAR RISK EVENT PREDICTION AND USES THEREOF

IPC classification:
G01N 33/68, C12Q 1/68
Applicant:
Somalogic Inc
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP15856718

BRAIDED SUTURE COAT

IPC classification:
A61B 17/06, A61B 17/04
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP15857032

SOLUBLE HETERODIMERIC T CELL RECEPTOR, AND PREPARATION METHOD AND USE THEREOF

IPC classification:
A61P 37/02, A61P 31/12, A61P 35/00, A61K 38/17, C12N 1/21, C12N 15/63, C12N 15/12, C07K 14/725
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP15858646

BIORESORBABLE-MAGNESIUM COMPOSITE

IPC classification:
B02C 1/00, A61F 2/28, A61L 27/46, A61L 27/44, A61L 27/02
Applicant:
Nanyang Technological University
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP15819911

NUCLEIC ACID COMPOUNDS FOR BINDING GROWTH DIFFERENTIATION FACTOR 11

IPC classification:
G01N 33/50, C12N 15/115
Applicant:
Somalogic Inc
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP15864987

USE OF TETRAHYDROPYRIDINES IN THE TREATMENT OF SODIUM CHANNEL RELATED DISEASE AND DISORDERS

IPC classification:
A61P 37/00, A61P 25/00, A61P 21/00, A61P 13/00, C07D 211/70, A61K 31/4458
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP16705668

SYNTHETIC PROCESS FOR PREPARING 2-((2-ETHOXY-2-OXOETHYL)(METHYL)AMINO)-2-OXOETHYL 5-TETRADECYLOXY)FURAN-2-CARBOXYLATE

IPC classification:
C07D 307/68, C07D 307/56
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP16706095

SYNTHETIC PROCESS FOR PREPARING 2-FUROIC ACID DERIVATIVES

IPC classification:
A61P 35/00, A61K 31/341, C07D 307/68
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP16753128

METHODS, COMPOSITIONS, AND KITS FOR TREATMENT OF CANCER

IPC classification:
C12P 21/00, C07K 16/22, A61K 39/395
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP17188594

HUMAN EMBRYONIC STEM CELL METHODS AND PODXL EXPRESSION

IPC classification:
G01N 33/50, A61K 35/545, C12Q 1/02, A61K 35/12, G01N 33/53, C12N 5/0735, C07K 16/28
Applicant:
Agency for Science, Technology and Research
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
The application has been published
EP17197260

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF

IPC classification:
G01N 33/68
Applicant:
Somalogic Inc
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
The application has been published
EP16742085

INJECTABLE POROUS DEVICE FOR TREATMENT OF DRY AND WET AGE-RELATED MACULAR DEGENERATION OR DIABETIC RETINOPATHY

IPC classification:
A61L 31/14, A61F 9/00, A61F 9/007, A61L 27/56
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP16738988

ARYL SULFONAMIDE COMPOUNDS AS CARBONIC ANHYDRASE INHIBITORS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 35/00, A61K 31/4166, C07D 233/32
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
Request for examination was made
EP17197440

DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

IPC classification:
C12N 15/113, C12N 15/867, C12N 15/85, C12N 9/90, C07K 14/47, C07K 14/16, C07K 14/00, A61K 48/00, A61K 35/28, A01K 67/027
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
The application has been published

Please Sign in to use this feature